News
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Optivar®
July 6, 2010 6:36 am | by Bio-Medicine.Org | CommentsDETROIT , July 6 /- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) has started shipping azelastine ophthalmic solution, 0.05%. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). This sterile...
Biodel Announces Schedule for Presentations at the 37th Annual Meeting and Exposition of the Controlled Release Society
July 6, 2010 6:35 am | by Bio-Medicine.Org | CommentsDANBURY, Conn. , July 6 /- Biodel Inc. (Nasdaq: BIOD ) announced today that the following oral and poster presentations describing results from studies of the company's product candidates will be presented during the 37th Annual Meeting and Exposition of the Controlled Release Society in...
Presentations at the Third European Stereotactic Radiation Therapy and Whole Body Radiotherapy Workshop Highlight Clinical Outcomes and Emerging Trends
July 6, 2010 6:34 am | by Bio-Medicine.Org | CommentsResults Presented in Spine, Lung, Liver and Prostate Treatment Emphasized the Benefits of Whole Body Radiosurgery SUNNYVALE, Calif. , July 6 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, today announced highlights from the Third European...
LCA-Vision sees 15 pct drop in 2Q procedures
July 6, 2010 5:45 am | by The Associated Press | CommentsLCA-Vision Inc., which operates laser vision surgery centers, said Tuesday that 15 percent fewer Lasik procedures were performed in the second quarter compared with the same time last year when the company operated more sites.The economic downturn has hit the company hard, leading to sharp...
FLIR releases uncooled, longwave thermal camera
July 5, 2010 11:35 pm | by I-Micronews | CommentsFLIR Systems, Inc. (NASDAQ: FLIR; Portland, OR, USA) announced the release of the new 640 × 480 resolution member of its popular Tau family of uncooled longwave camera cores. Still the smallest, lightest, lowest-power uncooled longwave thermal camera cores in their class, Tau 640 delivers...
Biosensors Comfortable Enough to Wear 24-7
July 5, 2010 8:36 pm | by Massachusetts Institute of Technology | CommentsA new kind of sensor could allow for long-term medical monitoring--without direct skin contact.
Targeting a Master Regulator of Disease
July 5, 2010 8:36 pm | by Massachusetts Institute of Technology | CommentsDrugmakers place big bets on the emerging science of microRNA.
News briefs from the July issue of Chest
July 5, 2010 8:35 pm | by EurekAlert | Comments(American College of Chest Physicians) News briefs from the July issue of Chest feature studies related to how weekend ICU admissions may be linked to increased risk of death and how biomass smoke may be linked to COPD.
Diagnostic blood test can identify rare lung disease
July 5, 2010 8:35 pm | by EurekAlert | Comments(University of Cincinnati Academic Health Center) Researchers at the University of Cincinnati and Cincinnati Children's Hospital Medical Center have found that a certain blood test can successfully identify lymphangioleiomyomatosis in some patients, eliminating the need for...
Antagonizing atherosclerosis
July 5, 2010 3:39 pm | by EurekAlert | Comments(Rockefeller University Press) Antibody-producing B cells promote atherosclerosis in mice, according to a study to be published online on July 5 in the Journal of Experimental Medicine. These findings came as a surprise, as prior studies had suggested that B cells help protect...
Kids now see fewer television ads for sweets and beverages, but more for fast food
July 5, 2010 3:39 pm | by EurekAlert | Comments(JAMA and Archives Journals) Children saw fewer television advertisements for certain foods, including those for sweets and beverages, in 2007 compared with 2003, according to a report posted online today that will appear in the September print issue of Archives of Pediatrics &...
Circadin is Approved in the EU for Treatment of Primary Insomnia in Patients Aged 55 or Over for up to 3 Months
July 5, 2010 3:38 pm | by Bio-Medicine.Org | CommentsTEL AVIV, Israel , July 5, 2010 /- Neurim Pharmaceuticals ( http://www.Neurim.com ) confirmed today that the European Commission (EC) has approved a change in treatment duration with Circadin from 3 to 13 weeks (3 months). Circadin is indicated for the treatment of primary insomnia in...
New tool to rule out coronary heart disease in primary care
July 5, 2010 3:36 pm | by EurekAlert | Comments(Canadian Medical Association Journal) A simple new rule can help primary care physicians rule out coronary heart disease in patients with chest pain, states a study published in CMAJ.
Depression symptoms show little change during the development and progression of Alzheimer's disease
July 5, 2010 3:36 pm | by EurekAlert | Comments(Rush University Medical Center) Researchers at Rush University Medical Center found that depressive symptoms show little change during the development and progression of Alzheimer's disease. The study suggests that depression is truly a risk factor for Alzheimer's disease and not...
Heart patients with anxiety disorder experience more cardiovascular events, deaths
July 5, 2010 3:36 pm | by EurekAlert | Comments(JAMA and Archives Journals) Among patients with heart disease, anxiety disorders appear to be associated with a higher risk of stroke, heart attack, heart failure and death, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
